← Back to Clinical Trials
Recruiting NCT06459986

NCT06459986 The Duration of Spinal Anaesthesia - a Prospective, Observational Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06459986
Status Recruiting
Phase
Sponsor Nordsjaellands Hospital
Condition Orthopedic Disorder
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2024-06-03
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2024-06-03 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Today, surgery in an ambulatory setting is preferred for many reasons. Total hip and knee arthroplasty (THA and TKA) are now procedures where patients can be sent home on the same day of the surgical procedure. However, this requires substantial knowledge of factors affecting the length of hospital stay. In this prospective, observational cohort study, we will investigate factors that affect the duration of spinal anaesthesia which is often used in THA and TKA. The aim is to gather enough data to be able to determine how local anaesthetic volume and dose affect the duration of spinal anaesthesia. This will enable us to decide whether spinal anaesthesia is a good option when performing TKA and THA in an ambulatory setting.

Eligibility Criteria

Inclusion Criteria: * Scheduled for elective orthopaedic surgical procedures performed in spinal anaesthesia * ASA 1-4. Exclusion Criteria: * Age \< 18 years * Anticoagulant medication therapy not paused according ESAIC/ESRA 2022 guidelines * Local infection at the lumbar puncture site * Bleeding disorder * Unable to cooperate with the spinal anaesthesia procedure.

Contact & Investigator

Central Contact

Kai HW Lange, MD

✉ Kai.henrik.wiborg.lange@regionh.dk

📞 +4531909730

Principal Investigator

Kai HW Lange, MD

PRINCIPAL INVESTIGATOR

Dept. of Anaesthesiology, Nordsjællands Hospital Hillerød, Denmark

Frequently Asked Questions

Who can join the NCT06459986 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Orthopedic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06459986 currently recruiting?

Yes, NCT06459986 is actively recruiting participants. Contact the research team at Kai.henrik.wiborg.lange@regionh.dk for enrollment information.

Where is the NCT06459986 trial being conducted?

This trial is being conducted at Hillerød, Denmark, Ringsted, Denmark.

Who is sponsoring the NCT06459986 clinical trial?

NCT06459986 is sponsored by Nordsjaellands Hospital. The principal investigator is Kai HW Lange, MD at Dept. of Anaesthesiology, Nordsjællands Hospital Hillerød, Denmark. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology